Wells Fargo
CLGN icon

Wells Fargo’s CollPlant Biotechnologies CLGN Stock Holding History

Wells Fargo’s Portfolio CLGN Stock Details CLGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$161 Sell
300
-1,700
-85% -$1.72K ﹤0.01% 6468
2025
Q4 		$2.8K Sell
2,000
-8,000
-80% -$16.4K ﹤0.01% 6183
2025
Q3 		$26.9K Sell
10,000
-2,405
-19% -$5.73K ﹤0.01% 5721
2025
Q2 		$16.9K Buy
12,405
+1,000
+9% +$2.07K ﹤0.01% 5828
2025
Q1 		$29.4K Buy
11,405
+3,000
+36% +$10.6K ﹤0.01% 5575
2024
Q4 		$30.3K Buy
8,405
+4,405
+110% +$17.9K ﹤0.01% 5643
2024
Q3 		$19.9K Buy
+4,000
New +$19.6K ﹤0.01% 5643
2022
Q2 		– Sell
-100
Closed -$1K – 6863
2022
Q1 		$1K Buy
+100
New +$1.1K ﹤0.01% 6767

Other funds holding CLGN

SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
LWMI
Legacy Wealth Management (Idaho) Boise, Idaho $201M AUM 259.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
WPC
Waters Parkerson & Co New Orleans, Louisiana $1.95B AUM 15.9% 1-Year Est. Return

Wells Fargo's CLGN Position: Q1 2026 in Review

Wells Fargo reduced its CollPlant Biotechnologies (CLGN) stake by 85% in Q1 2026, selling an estimated $1.72K and leaving 300 shares worth $161. The position accounts for ﹤0.01% of the portfolio, ranked #6468.

Wells Fargo first reported a position in CLGN in Q1 2022 and has held it in 8 quarters since. The position peaked at $30.3K in Q4 2024. 21 funds tracked by Wall St. Rank hold CLGN as of Q1 2026.

  • Wells Fargo held 300 shares of CollPlant Biotechnologies worth $161 as of Q1 2026.
  • Wells Fargo sold 1,700 CollPlant Biotechnologies shares in Q1 2026, an estimated $1.72K.
  • CollPlant Biotechnologies made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6468 holding.
  • Wells Fargo first reported a position in CollPlant Biotechnologies in Q1 2022 and has held it in 8 quarters since.
  • Wells Fargo's CollPlant Biotechnologies position peaked at $30.3K in Q4 2024.
  • 21 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.